PMID: 11337386May 5, 2001Paper

Effects of in vivo heregulin beta1 treatment in wild-type and ErbB gene-targeted mice depend on receptor levels and pregnancy

The American Journal of Pathology
S O'SheaS L Erickson

Abstract

Mice heterozygous (+/-) for either heregulin (HRG), ErbB2, or ErbB3 were created by gene targeting, resulting in the loss of one functional gene copy and an associated decrease in targeted protein. We examined the in vivo activity of recombinant HRG peptide, rHRG beta1 (amino acids 177 to 241), in the three heterozygous mouse lines and in wild-type (WT) mice, both pregnant and nonpregnant. Nonpregnant WT and HRG(+/-) mice of both sexes were sensitive to rHRG beta1 treatment as evidenced by a high mortality rate associated with abdominal enlargement and parietal cell loss. However, pregnant WT mice and ErbB2 and ErbB3 heterozygous mice treated with rHRG beta1 were less affected, with significantly lower mortality rates and a less severe abdominal phenotype. Histological analysis revealed extensive breast ductal hyperplasia in females of all genotypes after rHRG beta1 treatment. Hyperplasia of other epithelial tissues such as the pancreas and intestine and the growth of cardiac nerve bundles were also observed, independent of sex.

References

May 22, 1992·Science·W E HolmesG D Lewis
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·G D PlowmanM Shoyab
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M H KrausS A Aaronson
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·Y KokaiM I Greene
Nov 23, 1995·Nature·D Meyer, C Birchmeier
Jun 1, 1994·Molecular and Cellular Biology·S P SoltoffL C Cantley
Jan 1, 1995·Neuron·G CorfasG D Fischbach
May 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K LeitzelA Lipton
Dec 2, 1993·Nature·G D PlowmanS Buckley
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·P M GuyK L Carraway
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A Orr-UrtregerY Yarden
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·D Meyer, C Birchmeier
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·G D PlowmanM Shoyab
Apr 1, 1996·Digestive Diseases and Sciences·J R GoldenringR J Coffey
Apr 1, 1996·Molecular and Cellular Neurosciences·G Lemke
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·D E SyroidT J Kilpatrick
Mar 8, 2000·The Journal of Cell Biology·A N GarrattC Birchmeier
Apr 1, 1997·Journal of Mammary Gland Biology and Neoplasia·R Pinkas-KramarskiY Yarden

❮ Previous
Next ❯

Citations

Mar 22, 2003·Experimental Cell Research·Douglas L Falls
May 21, 2015·PLoS Neglected Tropical Diseases·Alessandra GuidiQuentin D Bickle
Dec 19, 2013·International Journal of Endocrinology and Metabolism·Wei-Jiang Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.